Dressler Dirk, Altenmueller Eckart, Bhidayasiri Roongroj, Bohlega Saeed, Chana Pedro, Chung Tae Mo, Frucht Steven, Garcia-Ruiz Pedro J, Kaelin Alain, Kaji Ryuji, Kanovsky Petr, Laskawi Rainer, Micheli Federico, Orlova Olga, Relja Maja, Rosales Raymond, Slawek Jaroslaw, Timerbaeva Sofia, Warner Thomas T, Saberi Fereshte Adib
Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625, Hannover, Germany.
Institute of Music Physiology and Musicians' Medicine, Hanover University of Music, Drama and Media, Hannover, Germany.
J Neural Transm (Vienna). 2016 Mar;123(3):251-8. doi: 10.1007/s00702-015-1453-x. Epub 2015 Sep 14.
Treatment of dystonias is generally symptomatic. To produce sufficient therapy effects, therefore, frequently a multimodal and interdisciplinary therapeutic approach becomes necessary, combining botulinum toxin therapy, deep brain stimulation, oral antidystonic drugs, adjuvant drugs and rehabilitation therapy including physiotherapy, occupational therapy, re-training, speech therapy, psychotherapy and sociotherapy. This review presents the recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders Special Task Force on Interdisciplinary Treatment of Dystonia. It reviews the different therapeutic modalities and outlines a strategy to adapt them to the dystonia localisation and severity of the individual patient. Hints to emerging and future therapies will be given.
肌张力障碍的治疗通常是对症治疗。因此,为了产生足够的治疗效果,经常需要采用多模式和跨学科的治疗方法,结合肉毒杆菌毒素治疗、深部脑刺激、口服抗肌张力障碍药物、辅助药物以及包括物理治疗、职业治疗、再训练、言语治疗、心理治疗和社会治疗在内的康复治疗。本综述介绍了IAB跨学科运动障碍特别工作组关于肌张力障碍跨学科治疗的建议。它回顾了不同的治疗方式,并概述了一种根据个体患者的肌张力障碍定位和严重程度调整这些治疗方式的策略。还将给出关于新兴和未来治疗方法的提示。